Shenzhen Vivolight Medical Device & Technology Co., Ltd, a Chinese medical device company nurtured and backed by the Chinese Academy of Sciences (CAS), has reportedly secured over RMB 100 million (USD 14.5 million) in strategic financing. The round was reportedly supported by Sinowisdom, Guangzhou Industrial Investment Fund, and Speedfox. The funds raised will be directed towards product development, clinical regulatory filings, and the expansion of the company’s market presence overseas.
Established in 2012, Vivolight has emerged as a prominent player in the laser medicine sector, with its product portfolio spanning coronary, peripheral, and neurological medical fields. The company boasts a compound annual growth rate of over 80% in product sales and its core product, a coronary OCT device, holds the largest market share among domestic products in its category.- Flcube.com
